Haemonetics shares jump after CSL Plasma NexSys rollout plan

Haemonetics (HAE) shares rose 12.4% in the morning session after CSL Plasma said it intends to deploy NexSys PCS devices and disposables across existing U.S. plasma collection centers by the close of 2027.